載入...
OP449 Inhibits Human Breast Cancer Growth without Adverse Metabolic Effects
Hyperinsulinemia is associated with a decrease in breast cancer recurrence-free survival and overall survival. Inhibition of insulin receptor signaling is associated with glycemic dysregulation. SET is a direct modulator of PP2A, which negatively regulates the PI3K/Akt/mTOR pathway. OP449, a SET inh...
Na minha lista:
| 發表在: | Endocr Relat Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5678946/ https://ncbi.nlm.nih.gov/pubmed/28830934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-17-0077 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|